BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35021606)

  • 1. Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.
    Wai CMM; Chen S; Phyu T; Fan S; Leong SM; Zheng W; Low LCY; Choo SN; Lee CK; Chung TH; Ban KHK; Ghosh S; Lie S; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Chuang SS; Au-Yeung RKH; Tan SY; Lim ST; Ong CK; Ho YH; Poon LM; De Mel S; Jeyasekharan AD; Chng WJ; Otto F; Quintanilla-Martinez L; Zanardi F; Iannelli F; Tripodo C; Pitt JJ; Ng SB
    Haematologica; 2022 Aug; 107(8):1864-1879. PubMed ID: 35021606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.
    Hayashino K; Yoshida C; Ayata Y; Yukawa R; Komura A; Nakamura M; Meguri Y; Yamamoto K; Oda W; Imajo K
    J Clin Exp Hematop; 2024; 64(1):52-58. PubMed ID: 38538319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia.
    Takata K; Hong ME; Sitthinamsuwan P; Loong F; Tan SY; Liau JY; Hsieh PP; Ng SB; Yang SF; Pongpruttipan T; Sukpanichnant S; Kwong YL; Hyeh Ko Y; Cho YT; Chng WJ; Matsushita T; Yoshino T; Chuang SS
    Am J Surg Pathol; 2015 Jan; 39(1):1-12. PubMed ID: 25188863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
    Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
    Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
    Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
    Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
    Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
    Kataoka K; Miyoshi H; Sakata S; Dobashi A; Couronné L; Kogure Y; Sato Y; Nishida K; Gion Y; Shiraishi Y; Tanaka H; Chiba K; Watatani Y; Kakiuchi N; Shiozawa Y; Yoshizato T; Yoshida K; Makishima H; Sanada M; Onozawa M; Teshima T; Yoshiki Y; Ishida T; Suzuki K; Shimada K; Tomita A; Kato M; Ota Y; Izutsu K; Demachi-Okamura A; Akatsuka Y; Miyano S; Yoshino T; Gaulard P; Hermine O; Takeuchi K; Ohshima K; Ogawa S
    Leukemia; 2019 Jul; 33(7):1687-1699. PubMed ID: 30683910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.
    de Mel S; Tan JZ; Jeyasekharan AD; Chng WJ; Ng SB
    Front Pediatr; 2018; 6():405. PubMed ID: 30705877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases.
    Kato S; Asano N; Miyata-Takata T; Takata K; Elsayed AA; Satou A; Takahashi E; Kinoshita T; Nakamura S
    Am J Surg Pathol; 2015 Apr; 39(4):462-71. PubMed ID: 25634749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
    Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
    Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification.
    Kato S; Yamashita D; Nakamura S
    J Clin Exp Hematop; 2020; 60(2):30-36. PubMed ID: 32565530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.
    Yim J; Koh J; Kim S; Song SG; Bae JM; Yun H; Sung JY; Kim TM; Park SH; Jeon YK
    Am J Surg Pathol; 2022 Apr; 46(4):486-497. PubMed ID: 34980830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome.
    Kato S; Hamada M; Okamoto A; Yamashita D; Miyoshi H; Arai H; Satou A; Gion Y; Sato Y; Tsuyuki Y; Miyata-Takata T; Takata K; Asano N; Takahashi E; Ohshima K; Tomita A; Hosoda W; Nakamura S; Okuno Y
    Blood Adv; 2024 May; 8(9):2138-2147. PubMed ID: 38429084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).
    Haverkos BM; Coleman C; Gru AA; Pan Z; Brammer J; Rochford R; Mishra A; Oakes CC; Baiocchi RA; Freud AG; Porcu P
    Discov Med; 2017 Mar; 23(126):189-199. PubMed ID: 28472613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.
    Ng SB; Chung TH; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Yin CC; Soong R; Jeyasekharan AD; Hoppe MM; Selvarajan V; Tan SY; Lim ST; Ong CK; Nairismägi ML; Maheshwari P; Choo SN; Fan S; Lee CK; Chuang SS; Chng WJ
    Haematologica; 2018 Feb; 103(2):278-287. PubMed ID: 29097495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.